Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-pacific region: Results of the study for monitoring antimicrobial resistance trends (SMART)

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 2981-2988

  Sheng, Wang Huei ^a   Badal, Robert E ^b   Hsueh, Po Ren ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Division of Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE ACT; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE DHA; BETA LACTAMASE NDM; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEMASE; ERTAPENEM; UNCLASSIFIED DRUG;

ABDOMINAL INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIUM ISOLATE; CHINA; CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; INDIA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; MULTIPLEX POLYMERASE CHAIN REACTION; NEW ZEALAND; NONHUMAN; PHILIPPINES; PRIORITY JOURNAL; PROTEUS VULGARIS; PROVIDENCIA RETTGERI; SINGAPORE; SOUTH KOREA; TAIWAN; THAILAND; VIET NAM;

ANTI-BACTERIAL AGENTS; ASIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INTRAABDOMINAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; PACIFIC OCEAN;

EID: 84879017742     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00971-12     Document Type: Article

References (27)

1. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y. 2006. Influx of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
2. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. (Pubitemid 351249250)
3. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, Karumudi U, Tolaney P, Quale J. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020. (Pubitemid 40917631)
4. Jacoby GA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182.
5. Brigante G, Luzzaro F, Perilli M, Lombardi G, Colì A, Rossolini GM, Amicosante G, Toniolo A. 2005. Evolution of CTX-M-type betalactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25:157-162. (Pubitemid 40138953)
6. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. 2010. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 54:5099-5104.
7. Paterson DL, Bonomo RA. 2005. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
8. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. 2009. Emergence of high levels of extended-spectrum-β-lactamaseproducing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program. Antimicrob. Agents Chemother. 53:3280-3284.
9. Hsueh PR, Snyder TA, Dinubile MJ, Satischandran V, McCarroll K, Chow JW, 2004 Asia-Pacific Team SMART. 2006. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int. J. Antimicrob. Agents 28:238-243. (Pubitemid 44223984)
10. Clinical and Laboratory Standard Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standard Institute, Wayne, PA.
11. Clinical and Laboratory Standard Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22. Clinical and Laboratory Standard Institute, Wayne, PA.
12. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenemhydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161. (Pubitemid 32230996)
13. Cohen Stuart J, Dierikx C, Al Naiemi N, Karczmarek A, Van Hoek AH, Vos P, Fluit AC, Scharringa J, Duim B, Mevius D, Leverstein-Van Hall MA. 2010. Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J. Antimicrob. Chemother. 65:1377-1381.
14. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490-495.
15. Bonnet R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. (Pubitemid 38040170)
16. Cantón R, Coque TM. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
17. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. (Pubitemid 47072053)
18. Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, André C, Scientific Committee of ONERBA. 2009. Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting. J. Antimicrob. Chemother. 63: 1205-1214.
19. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
20. Sasaki T, Hirai I, Niki M, Nakamura T, Komalamisra C, Maipanich W, Kusolsuk T, Sa-Nguankiat S, Pubampen S, Yamamoto Y. 2010. High prevalence of CTX-M β-lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J. Antimicrob. Chemother. 65:666-668.
21. Kim J, Kang HY, Lee Y. 2008. The identification of CTX-M-14, TEM-52, and CMY-1 enzymes in Escherichia coli isolated from the Han River in Korea. J. Microbiol. 46:478-481.
22. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, Heck M, Savelkoul P, Vandenbroucke-Grauls C, van der Zwaluw K, Huijsdens X, Kluytmans J. 2011. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg. Infect. Dis. 17:1216-1222.
23. Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM. 2001. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother. 48:839-852. (Pubitemid 33735320)
24. Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Nakai I, Kofuku T, Orita T, Wada Y, Jikimoto T, Kinoshita S, Miyamoto K, Hirai I, Yamamoto Y. 2010. Laboratory surveillance for prospective plasmid-mediated AmpC β-lactamases in the Kinki region of Japan. J. Clin. Microbiol. 48:3267-3273.
25. Mata C, Miró E, Toleman M, Rivera MA, Walsh TR, Navarro F. 2011. Association of blaDHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospital. Clin. Microbiol. Infect. 17:1514-1517.
26. Alvarez M, Tran JH, Chow N, Jacoby GA. 2004. Epidemiology of conjunctive plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48:533-537. (Pubitemid 38141713)
27. Bell JM, Turnidge JD, Jones RN, Asia-Pacific Participants SENTRY. 2003. Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific Region: results from the SENTRYAntimicrobial Surveillance Program, 1998 to 2001. Antimicrob. Agents Chemother. 47:3989-3993. (Pubitemid 37485024)